☰

Rachel M. Leskowitz, Ph.D. - Publications

Affiliations: 
2014 Cell and Molecular Biology University of Pennsylvania, Philadelphia, PA, United States 
Area:
Cell Biology, Immunology, Virology Biology
Tree Info Grants Similar researchers PubMed Report error

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Bagley SJ, Logun M, Fraietta JA, Wang X, Desai AS, Bagley LJ, Nabavizadeh A, Jarocha D, Martins R, Maloney E, Lledo L, Stein C, Marshall A, Leskowitz R, Jadlowsky JK, et al. Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results. Nature Medicine. PMID 38480922 DOI: 10.1038/s41591-024-02893-z  0.324
2022 Garfall AL, Cohen AD, Susanibar-Adaniya SP, Hwang WT, Vogl DT, Waxman AJ, Lacey SF, Gonzalez VE, Fraietta JA, Gupta M, Kulikovskaya I, Tian L, Chen F, Koterba N, Bartoszek RL, ... ... Leskowitz R, et al. Anti-BCMA/CD19 CAR T cells with early immunomodulatory maintenance for multiple myeloma responding to initial or later-line therapy. Blood Cancer Discovery. PMID 36413381 DOI: 10.1158/2643-3230.BCD-22-0074  0.339
2020 Gladney W, Hexner E, Salas-McKee J, Fesnak A, Jadlowsky J, Plesa G, Leskowitz R, Chew A, Dai A, Gohil M, Xu J, Siegel D, Lacey S, Davis M, June C. Pre-clinical development of multiplex-CRISPR-edited cell and gene therapy products Cytotherapy. 22: S35. DOI: 10.1016/J.Jcyt.2020.03.026  0.5
2019 Gohil M, Dai A, Mackey S, Negorev D, Hennesy N, O'Rourke M, Lamontagne A, Holland D, Leskowitz R, Xu J, Ozerova M, McKee J, Pequignot E, Siegel D, Schuster S, et al. Myeloid derived suppressor cells (MDSCS) reduce the manufacturing feasibilty of gene modified T cells. Cytotherapy. 21: S19. DOI: 10.1016/J.Jcyt.2019.03.315  0.48
2018 Ohayon Y, Corl C, Leskowitz R, Malykhin A, Arostegui S, Hennesy N, Ngo S, Levine B, Siegel D, Fesnak A, Davis M. Robust automated cell counter and viability measurement for engineered T cell product release Cytotherapy. 20: S69. DOI: 10.1016/J.Jcyt.2018.02.193  0.416
2017 Davis M, Fesnak A, Leskowitz R, McKee J, Ohayon Y, Corl C, Malykhin A, Fraietta J, Joseph Melenhorst J, June C, Schuster S, Levine B. Predictors of manufacturing (MFG) success for chimeric antigen receptor (CAR) T cells in Non-Hodgkin Lymphoma (NHL) Cytotherapy. 19: S118-S119. DOI: 10.1016/J.Jcyt.2017.02.190  0.463
2015 Levine B, Leskowitz R, Davis M. Personalized gene therapy locks out HIV, paving the way to control virus without antiretroviral drugs. Expert Opinion On Biological Therapy. 15: 831-43. PMID 25947115 DOI: 10.1517/14712598.2015.1035644  0.347
2014 Leskowitz R, Fogg MH, Zhou XY, Kaur A, Silveira EL, Villinger F, Lieberman PM, Wang F, Ertl HC. Adenovirus-based vaccines against rhesus lymphocryptovirus EBNA-1 induce expansion of specific CD8+ and CD4+ T cells in persistently infected rhesus macaques. Journal of Virology. 88: 4721-35. PMID 24522914 DOI: 10.1128/Jvi.03744-13  0.696
2013 Silveira EL, Fogg MH, Leskowitz RM, Ertl HC, Wiseman RW, O'Connor DH, Lieberman P, Wang F, Villinger F. Therapeutic vaccination against the rhesus lymphocryptovirus EBNA-1 homologue, rhEBNA-1, elicits T cell responses to novel epitopes in rhesus macaques. Journal of Virology. 87: 13904-10. PMID 24089556 DOI: 10.1128/Jvi.01947-13  0.687
2013 Leskowitz RM, Zhou XY, Villinger F, Fogg MH, Kaur A, Lieberman PM, Wang F, Ertl HC. CD4+ and CD8+ T-cell responses to latent antigen EBNA-1 and lytic antigen BZLF-1 during persistent lymphocryptovirus infection of rhesus macaques. Journal of Virology. 87: 8351-62. PMID 23698300 DOI: 10.1128/Jvi.00852-13  0.638
2011 Chiang CL, Hagemann AR, Leskowitz R, Mick R, Garrabrant T, Czerniecki BJ, Kandalaft LE, Powell DJ, Coukos G. Day-4 myeloid dendritic cells pulsed with whole tumor lysate are highly immunogenic and elicit potent anti-tumor responses. Plos One. 6: e28732. PMID 22194898 DOI: 10.1371/Journal.Pone.0028732  0.413
2011 Lasaro MO, Haut LH, Zhou X, Xiang Z, Zhou D, Li Y, Giles-Davis W, Li H, Engram JC, Dimenna LJ, Bian A, Sazanovich M, Parzych EM, Kurupati R, Small JC, ... ... Leskowitz RM, et al. Vaccine-induced T cells provide partial protection against high-dose rectal SIVmac239 challenge of rhesus macaques. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 417-26. PMID 21081905 DOI: 10.1038/Mt.2010.238  0.586
2010 Hagemann AR, Leskowitz R, Cohen GH, Coukos G, Powell DJ. Abstract 2410: Development of a genetically-optimized whole tumor cell vaccine for ovarian cancer using HSV-derived glycoprotein D Cancer Research. 70: 2410-2410. DOI: 10.1158/1538-7445.Am10-2410  0.528
Show low-probability matches.